Advisors Capital Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $404K | Buy |
1,043
+198
| +23% | +$73.4K | ﹤0.01% | 470 |
|
|
2026
Q1 | $247K | Sell |
845
-61
| -7% | -$20K | ﹤0.01% | 512 |
|
|
2025
Q4 | $318K | Sell |
906
-111
| -11% | -$37.5K | ﹤0.01% | 484 |
|
|
2025
Q3 | $329K | Sell |
1,017
-314
| -24% | -$97.7K | ﹤0.01% | 464 |
|
|
2025
Q2 | $518K | Buy |
1,331
+176
| +15% | +$70.8K | 0.01% | 369 |
|
|
2025
Q1 | $503K | Sell |
1,155
-382
| -25% | -$153K | 0.01% | 360 |
|
|
2024
Q4 | $567K | Sell |
1,537
-256
| -14% | -$107K | 0.01% | 358 |
|
|
2024
Q3 | $933K | Buy |
1,793
+88
| +5% | +$47K | 0.02% | 299 |
|
|
2024
Q2 | $924K | Buy |
1,705
+229
| +16% | +$121K | 0.02% | 298 |
|
|
2024
Q1 | $766K | Buy |
1,476
+1
| +0.1% | +$497 | 0.01% | 312 |
|
|
2023
Q4 | $696K | Buy |
+1,475
| New | +$682K | 0.01% | 315 |
|
|
2023
Q3 | – | Sell |
-775
| Closed | -$344K | – | 430 |
|
|
2023
Q2 | $344K | Sell |
775
-66
| -8% | -$30.4K | 0.01% | 358 |
|
|
2023
Q1 | $387K | Buy |
841
+20
| +2% | +$9.52K | 0.01% | 331 |
|
|
2022
Q4 | $421K | Sell |
821
-13
| -2% | -$6.6K | 0.01% | 330 |
|
|
2022
Q3 | $409K | Sell |
834
-221
| -21% | -$106K | 0.01% | 342 |
|
|
2022
Q2 | $509K | Sell |
1,055
-18
| -2% | -$8.9K | 0.02% | 297 |
|
|
2022
Q1 | $527K | Buy |
1,073
+272
| +34% | +$124K | 0.01% | 307 |
|
|
2021
Q4 | $371K | Sell |
801
-49
| -6% | -$20.6K | 0.01% | 342 |
|
|
2021
Q3 | $317K | Sell |
850
-1
| -0.1% | -$380 | 0.01% | 343 |
|
|
2021
Q2 | $325K | Buy |
851
+56
| +7% | +$21.4K | 0.01% | 322 |
|
|
2021
Q1 | $285K | Buy |
795
+38
| +5% | +$12.2K | 0.01% | 320 |
|
|
2020
Q4 | $243K | Sell |
757
-71
| -9% | -$21.8K | 0.01% | 313 |
|
|
2020
Q3 | $223K | Buy |
828
+51
| +7% | +$13.7K | 0.01% | 283 |
|
|
2020
Q2 | $204K | Sell |
777
-55,265
| -99% | -$14.7M | 0.01% | 284 |
|
|
2020
Q1 | $12.7M | Buy |
56,042
+2,086
| +4% | +$568K | 0.81% | 47 |
|
|
2019
Q4 | $16.3M | Buy |
53,956
+1,356
| +3% | +$373K | 0.76% | 46 |
|
|
2019
Q3 | $12.6M | Buy |
52,600
+354
| +0.7% | +$97K | 0.69% | 53 |
|
|
2019
Q2 | $14.7M | Buy |
52,246
+2,634
| +5% | +$720K | 0.88% | 41 |
|
|
2019
Q1 | $14.3M | Sell |
49,612
-4,309
| -8% | -$1.25M | 0.89% | 44 |
|
|
2018
Q4 | $14.2M | Sell |
53,921
-4,389
| -8% | -$1.21M | 1.03% | 30 |
|
|
2018
Q3 | $16M | Sell |
58,310
-3,166
| -5% | -$822K | 1.04% | 29 |
|
|
2018
Q2 | $14.6M | Sell |
61,476
-584
| -0.9% | -$135K | 1.01% | 34 |
|
|
2018
Q1 | $13.6M | Sell |
62,060
-2,559
| -4% | -$601K | 1.03% | 34 |
|
|
2017
Q4 | $14.5M | Sell |
64,619
-3,037
| -4% | -$647K | 1.15% | 29 |
|
|
2017
Q3 | $12.8M | Buy |
67,656
+82
| +0.1% | +$15.6K | 1.04% | 31 |
|
|
2017
Q2 | $12.7M | Sell |
67,574
-105
| -0.2% | -$18.9K | 1.04% | 33 |
|
|
2017
Q1 | $11.2M | Sell |
67,679
-369
| -0.5% | -$58.7K | 0.96% | 35 |
|
|
2016
Q4 | $9.78M | Buy |
68,048
+2,623
| +4% | +$351K | 0.94% | 37 |
|
|
2016
Q3 | $8.2M | Buy |
65,425
+2,606
| +4% | +$336K | 0.8% | 45 |
|
|
2016
Q2 | $8.25M | Sell |
62,819
-3,896
| -6% | -$533K | 0.85% | 42 |
|
|
2016
Q1 | $9.27M | Sell |
66,715
-6,602
| -9% | -$882K | 0.94% | 40 |
|
|
2015
Q4 | $10.2M | Buy |
73,317
+22,784
| +45% | +$3.14M | 1.03% | 39 |
|
|
2015
Q3 | $7.08M | Buy |
50,533
+14,488
| +40% | +$2.18M | 0.77% | 48 |
|
|
2015
Q2 | $5.92M | Buy |
36,045
+2,068
| +6% | +$330K | 0.64% | 59 |
|
|
2015
Q1 | $5.25M | Buy |
33,977
+581
| +2% | +$82.7K | 0.59% | 62 |
|
|
2014
Q4 | $4.2M | Sell |
33,396
-50
| -0.1% | -$6.18K | 0.51% | 71 |
|
|
2014
Q3 | $4M | Buy |
33,446
+1,841
| +6% | +$211K | 0.51% | 75 |
|
|
2014
Q2 | $3.4M | Buy |
31,605
+2,180
| +7% | +$225K | 0.46% | 83 |
|
|
2014
Q1 | $2.93M | Buy |
29,425
+2,730
| +10% | +$247K | 0.45% | 81 |
|
|
2013
Q4 | $2.47M | Buy |
26,695
+3,211
| +14% | +$285K | 0.42% | 87 |
|
|
2013
Q3 | $1.96M | Buy |
23,484
+2,960
| +14% | +$254K | 0.4% | 88 |
|
|
2013
Q2 | $1.68M | Buy |
+20,524
| New | +$1.54M | 0.38% | 87 |
|
Other funds holding ELV
Advisors Capital Management's ELV Position: Q2 2026 in Review
Advisors Capital Management increased its Elevance Health (ELV) stake by 23% in Q2 2026, buying an estimated $73.4K and bringing the position to 1,043 shares worth $404K. The position accounts for ﹤0.01% of the portfolio, ranked #470.
Advisors Capital Management first reported a position in ELV in Q2 2013 and has held it in 52 quarters since. The position peaked at $16.3M in Q4 2019. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Advisors Capital Management held 1,043 shares of Elevance Health worth $404K as of Q2 2026.
- Advisors Capital Management bought 198 Elevance Health shares in Q2 2026, an estimated $73.4K.
- Elevance Health made up ﹤0.01% of Advisors Capital Management's portfolio in Q2 2026, its #470 holding.
- Advisors Capital Management first reported a position in Elevance Health in Q2 2013 and has held it in 52 quarters since.
- Advisors Capital Management's Elevance Health position peaked at $16.3M in Q4 2019.
- 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Advisors Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.